Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
12 p, 503.9 KB Excellent Response to OnabotulinumtoxinA : Different Definitions, Different Predictors / Ornello, Raffaele (University of L'Aquila) ; Baraldi, Carlo (AOU Policlinico di Modena) ; Ahmed, Fayyaz (Hull University Teaching Hospitals) ; Negro, Andrea (Sapienza University) ; Miscio, Anna Maria (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ; Santoro, Antonio (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Russo, Antonio (University of Campania "Luigi Vanvitelli") ; Silvestro, Marcello (University of Campania "Luigi Vanvitelli") ; Cevoli, Sabina (IRCCS Istituto delle Scienze Neurologiche di Bologna) ; Brunelli, Nicoletta (Campus Bio-Medico University Hospital (Itàlia)) ; Vernieri, Fabrizio (Campus Bio-Medico University Hospital (Itàlia)) ; Grazzi, Licia (IRCCS Foundation "Carlo Besta" Neurological Institute) ; Pani, Luca (VeraSci (Estats Units d'Amèrica)) ; Andreou, Anna P (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ; Lambru, Giorgio (Guy's and St Thomas' NHS Foundation Trust (Regne Unit)) ; Frattale, Ilaria (Tor Vergata University) ; Kamm, Katharina (Ludwig Maximilians University München) ; Ruscheweyh, Ruth (Ludwig Maximilians University München) ; Russo, Marco (Azienda USL-IRCCS di Reggio Emilia) ; Torelli, Paola (University of Parma) ; Filatova, Elena (Sechenov First Moscow State Medical University) ; Latysheva, Nina (Sechenov First Moscow State Medical University) ; Gryglas-Dworak, Anna (Headache Center Wroclaw) ; Straburzyński, Marcin (University of Warmia and Mazury) ; Butera, Calogera (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Colombo, Bruno (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Filippi, Massimo (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martelletti, Paolo (Sapienza University) ; Guerzoni, Simona (University of Modena and Reggio Emilia) ; Sacco, Simona (University of L'Aquila) ; Universitat Autònoma de Barcelona
The identification of patients who can benefit the most from the available preventive treatments is important in chronic migraine. We explored the rate of excellent responders to onabotulinumtoxinA in a multicenter European study and explored the predictors of such response, according to different definitions. [...]
2022 - 10.3390/ijerph191710975
International journal of environmental research and public health, Vol. 19 (september 2022)  
2.
14 p, 810.0 KB Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients / Ornello, Raffaele (University of L'Aquila. Department of Applied Clinical Sciences and Biotechnology) ; Ahmed, Fayyaz (Hull University Teaching Hospitals. Department of Neurosciences) ; Negro, Andrea (Sapienza University. Department of Clinical and Molecular Medicine) ; Miscio, Anna Maria (Fondazione IRCCS "Casa Sollievo della Sofferenza". Unit of Neurology) ; Santoro, Antonio (Fondazione IRCCS "Casa Sollievo della Sofferenza". Unit of Neurology) ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Russo, Antonio (University of Campania "Luigi Vanvitelli". Department of Medical, Surgical, Neurological, Metabolic, and Aging Sciences) ; Silvestro, Marcello (University of Campania "Luigi Vanvitelli". Department of Medical, Surgical, Neurological, Metabolic, and Aging Sciences) ; Cevoli, Sabina (IRCCS Istituto delle scienze Neurologiche di Bologna) ; Brunelli, Nicoletta (Campus Bio-Medico University Hospital. Headache and Neurosonology Unit) ; Vernieri, Fabrizio (Campus Bio-Medico University Hospital. Headache and Neurosonology Unit) ; Grazzi, Licia (IRCCS Foundation "Carlo Besta" Neurological Institute. Neurology Department) ; Baraldi, Carlo (University of Modena and Reggio Emilia. Department of Biomedical, Metabolic and Neural Sciences) ; Guerzoni, Simona (University of Modena and Reggio Emilia. Department of Biomedical, Metabolic and Neural Sciences) ; Andreou, Anna P. (Guy's and St Thomas' NHS Foundation Trust. Headache Service) ; Lambru, Giorgio (Guy's and St Thomas' NHS Foundation Trust. Headache Service) ; Kamm, Katharina (Ludwig Maximilians University München. Department of Neurology) ; Ruscheweyh, Ruth (Ludwig Maximilians University München. Department of Neurology) ; Russo, Marco (Azienda USL-IRCCS di Reggio Emilia. Neuromotor and Rehabilitation Department) ; Torelli, Paola (University of Parma. Headache Center) ; Filatova, Elena (Sechenov First Moscow State Medical University (Sechenov University). Department of Neurology) ; Latysheva, Nina (Sechenov First Moscow State Medical University (Sechenov University). Department of Neurology) ; Gryglas-Dworak, Anna (Headache Center Wroclaw) ; Straburzyński, Marcin (Headache Clinic (Warsaw, Poland)) ; Butera, Calogera (IRCCS San Raffaele Scientific Institute. Neurophysiology Service) ; Colombo, Bruno (IRCCS San Raffaele Scientific Institute (Milà, Itàlia). Neurology Unit) ; Filippi, Massimo (IRCCS San Raffaele Scientific Institute. Neurorehabilitation Unit) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martelletti, Paolo (Sapienza University. Department of Clinical and Molecular Medicine) ; Sacco, Simona (University of L'Aquila. Department of Applied Clinical Sciences and Biotechnology) ; Universitat Autònoma de Barcelona
Migraine is mostly a female disorder because of its lower prevalence in men. Less than 20% of patients included in the available studies on migraine treatments are men; hence, the evidence on migraine treatments might not apply to men. [...]
2021 - 10.1007/s40122-021-00328-y
Pain and Therapy, Vol. 10 (september 2021) , p. 1605-1618  
3.
14 p, 826.8 KB Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine : Insights from a Real-Life European Multicenter Study / Ornello, Raffaele (University of L'Aquila. Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology) ; Ahmed, Fayyaz (Hull University Teaching Hospitals) ; Negro, Andrea (Sapienza University) ; Miscio, Anna Maria (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ; Santoro, Antonio (Fondazione IRCCS "Casa Sollievo Della Sofferenza") ; Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Russo, Antonio (University of Campania "Luigi Vanvitelli") ; Silvestro, Marcello (University of Campania "Luigi Vanvitelli".) ; Cevoli, Sabina (IRCCS Istituto Delle Scienze Neurologiche Di Bologna) ; Brunelli, Nicoletta (Campus Bio-Medico University Hospital) ; Vernieri, Fabrizio (Campus Bio-Medico University Hospital) ; Grazzi, Licia (IRCCS Foundation "Carlo Besta" Neurological Institute) ; Baraldi, Carlo (University of Modena and Reggio Emilia) ; Guerzoni, Simona (University of Modena and Reggio Emilia) ; Andreou, Anna P. (Guy's and St Thomas' NHS Foundation Trust) ; Lambru, Giorgio (Guy's and St Thomas' NHS Foundation Trust) ; Frattale, Ilaria (Tor Vergata University) ; Kamm, Katharina (Ludwig Maximilians University München) ; Ruscheweyh, Ruth (Ludwig Maximilians University München) ; Russo, Marco (Azienda USL-IRCCS Di Reggio Emilia) ; Torelli, Paola (University of Parma) ; Filatova, Elena (Sechenov First Moscow State Medical University) ; Latysheva, Nina (Sechenov First Moscow State Medical University) ; Gryglas-Dworak, Anna (Headache Center Wroclaw) ; Straburzynski, Marcin (Terapia Neurologiczna Samodzielni) ; Butera, Calogera (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Colombo, Bruno (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Filippi, Massimo (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martelletti, Paolo (Sapienza University'Andrea) ; Sacco, Simona (University of L'Aquila) ; Universitat Autònoma de Barcelona
OnabotulinumtoxinA (BT-A) quarterly was the first treatment approved specifically for chronic migraine (CM). It is unclear whether three cycles are better than two to assess early BT-A response. We performed a retrospective analysis on real-life prospectively collected data in 16 European headache centers. [...]
2021 - 10.1007/s40122-021-00253-0
Pain and Therapy, Vol. 10 (march 2021) , p. 637-650  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.